Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

Novo's drug is semaglutide, known as Ozempic for diabetics and Wegovy for weight loss; Lilly's is tirzepatide, known as Mounjaro or Zepbound. Around 12 per cent of Americans have already tried ...

Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits of Ozempic after fellow top Trump adviser, Robert F. Kennedy Jr., suggested ...

I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I thought since it's a smaller amount than what a doctor was giving out, it ...

Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages ...

Elon Musk, 53, shared on Wednesday that he uses Mounjaro, a weight-loss medication, after previously endorsing similar drugs ...

FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...

A study suggests that GLP-1 agonist drugs, like Ozempic, may reduce overdose risks and aid in addiction treatment. Further ...

Elon Musk/X Mounjaro, like Ozempic, is a GLP-1 inhibitor – a class of drugs developed to help people with diabetes regulate their blood glucose and insulin levels. However, Americans have ...

Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...

As of this summer, about 12% of U.S. adults said they had been on a GLP-1 receptor agonist — the class of drugs that includes Ozempic and Wegovy — for either weight loss or treatment of ...